Tissue Genesis is the first company to conduct an FDA-approved clinical trial for cell therapy using adipose-derived stem cells isolated at the point-of-care with an automated system. Their expertise, experience...Read
Sparton Medical supported the technology transfer of the Angel Whole Blood Separation System from a manufacturing facility in Italy to the United States for Cytomedix. The system produces autologous platelet-rich plasma.
BioMarker Strategies, a tissue-based molecular pathology company, contracted us to custom develop a platform that would standardize and automate biopsy sample preparation and live cell molecular analysis for their novel biomarker testing system.